Quantitative real-time RT-PCR and chromogenic in situ hybridization: precise methods to detect HER-2 status in breast carcinoma

BACKGROUND: HER-2 gene testing has become an integral part of breast cancer patient diagnosis. The most commonly used assay in the clinical setting for evaluating HER-2 status is immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). These procedures permit correlation between HER...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosa, Fabíola E, Silveira, Sara M, Silveira, Cássia GT, Bérgamo, Nádia A, Neto, Francisco A Moraes, Domingues, Maria AC, Soares, Fernando A, Caldeira, José RF, Rogatto, Silvia R
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667535/
https://www.ncbi.nlm.nih.gov/pubmed/19309522
http://dx.doi.org/10.1186/1471-2407-9-90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2667535/
https://www.ncbi.nlm.nih.gov/pubmed/19309522
http://dx.doi.org/10.1186/1471-2407-9-90

Ejemplares similares